RE:What is 18% referring to? anyone...This 18% has to be MB in my opinion since I understand that Toraymyxin can remove up to
90% of endotoxin. So we need a lot of clarification here. Where is this 18% mortality benefit coming from? This is a very significant number that could trigger an FDA approval somewhere
down the road in my opinion.
"A novel therapy for certain patients in septic shock, Toraymyxin™ is a medical device specifically targeted at those with elevated levels of endotoxin in the blood. Toraymyxin™ is a direct hemoperfusion adsorption column that has been shown to be highly effective in removing endotoxin. Studies have shown that Toraymyxin™ can remove up to 90 percent of an endotoxemic patient's circulating endotoxin when administered twice within a 24 hour period."
https://www.marketwired.com/press-release/fda-accepts-spectrals-expanded-access-protocol-for-toraymyxin-tsx-edt-2137608.htm